Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Shares Outstanding (2021 - 2025)

PAVmed (PAVM) has 5 years of Shares Outstanding data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Shares Outstanding changed N/A year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, changed N/A, while the annual FY2024 figure was $1.4 million, 8.25% up from the prior year.
  • Shares Outstanding reached $19376.0 in Q3 2025 per PAVM's latest filing, down from $20335.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $8.0 million in Q3 2023 and bottomed at $19376.0 in Q3 2025.
  • Average Shares Outstanding over 5 years is $1.7 million, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: plummeted 81.23% in 2024, then surged 1159.61% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $5.8 million in 2021, then rose by 9.43% to $6.3 million in 2022, then crashed by 79.28% to $1.3 million in 2023, then increased by 8.25% to $1.4 million in 2024, then grew by 6.12% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $16.8 million in Q1 2025.